CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pronova BioPharma Norge AS v. Par Pharmaceutical Inc.

1:10-cv-00801

Overview

Case Number 1:10-cv-00801
Filing Date 2010-09-20
Status Terminated
Termination Date 2011-07-27
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Par Pharmaceutical Inc. Operating Company

Represented By

1 Attorneys Listed

Par Pharmaceutical Companies Inc. Operating Company

Represented By

1 Attorneys Listed

Counter Defendant

Pronova BioPharma Norge AS Operating Company

Represented By

3 Attorneys Listed

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7732488
Pharmaceutical composition comprising low concentrations of environmental pollutants
Filed: 2003-07-08
Issued: 2010-06-08
Expired (Term Ended) +672d PTA
Expires: 2025-05-10

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+672 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

6

Dispositive

0

Granted

0

Denied

0

Pending / Review

6

Motions by Category

Claim Construction / Markman Filing 6

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
REDACTED VERSION of (57 in 1:10-cv-00801-SLR -MPT) Claim Construction Answering Brief Redacted Public Version of Defendants' Answering Claim Construction Brief ...
Entry #59 • 2011-07-15 Document →
Claim Construction / Markman Filing Pending / Under Review
SEALED CLAIM CONSTRUCTION ANSWERING BRIEF re 56 Claim Construction Opening Brief filed by Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc.. (Ferguson,...
Entry #57 • 2011-07-08 Document →
Claim Construction / Markman Filing Pending / Under Review
DECLARATION re 57 Claim Construction Answering Brief of Dr. Frank M. Sacks, M.D. by Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc.. (Attachments: # ...
Entry #58 • 2011-07-08 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION OPENING BRIEF filed by Pronova BioPharma Norge AS. (Lydon, Tiffany) (Entered: 06/24/2011)
Entry #56 • 2011-06-24 Document →
Claim Construction / Markman Filing Pending / Under Review
STIPULATION to extend time for filing simultaneous opening and responsive claim construction briefs to June 24, 2011 and July 20, 2011, respectively by Par Phar...
Entry #49 • 2011-06-08 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM Construction Chart by Pronova BioPharma Norge AS. (Hong, Caroline) (Entered: 06/03/2011)
Entry #48 • 2011-06-03 Document →

Docket Entries

(66 total)
Pleading / Complaint

COMPLAINT filed against Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-785508.) - filed by Pronova BioPharma Norge AS. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 09/21/2010)

Entry #1 • 2010-09-20
1
Pleading / Complaint

COMPLAINT filed against Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-785508.) - filed by Pronova BioPharma Norge AS. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 09/21/2010)

Entry #1 • 2010-09-20
2
Pleading / Complaint

COMPLAINT filed against Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 311-785508.) - filed by Pronova BioPharma Norge AS. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 09/21/2010)

Entry #1 • 2010-09-20
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dmp, ) (Entered: 09/21/2010)

Entry #2 • 2010-09-20
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,732,488 B2; (dmp, ) (Entered: 09/21/2010)

Entry #3 • 2010-09-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc